Enovis (ENOV) Non-Current Debt (2010 - 2026)
Enovis' (ENOV) quarterly Non-Current Debt came in at $1.3 billion in Q3 2026, down 7.82% year-over-year from $1.4 billion in Q3 2025, and down 3.13% quarter-over-quarter from $1.3 billion in Q2 2026.
Analysis
Enovis (ENOV) Non-Current Debt (2010 - 2026) Analysis & Trends
Enovis (ENOV) has reported Non-Current Debt for 17 consecutive years, with $1.3 billion the latest figure, recorded in Q3 2026.
- On a quarterly basis, Non-Current Debt fell 7.82% year-over-year to $1.3 billion in Q3 2026; TTM through Jul 2026 was $1.3 billion, a 7.82% decrease from a year earlier, with the FY2025 full-year figure at $1.3 billion, down 2.46% from the prior year.
- Non-Current Debt was $1.3 billion for Q3 2026 at Enovis, down from $1.3 billion in the prior quarter.
- Over five years, Non-Current Debt peaked at $2.1 billion in Q2 2022 and troughed at $259.3 million in Q4 2022.
- A 5-year average of $1.0 billion and a median of $1.3 billion in 2025 frame the typical range for Non-Current Debt.
- Across the five-year window, Non-Current Debt slumped 87.57% in 2022 and surged 369.67% in 2024, its largest moves.
- Over 5 years, Non-Current Debt stood at $259.3 million in 2022, then jumped by 79.79% to $466.2 million in 2023, then surged by 185.2% to $1.3 billion in 2024, then declined by 2.46% to $1.3 billion in 2025, then declined by 0.95% to $1.3 billion in 2026.
- The last three Non-Current Debt figures came in at $1.3 billion (Q3 2026), $1.3 billion (Q2 2026), and $1.3 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.92 Bn | 176.31 Bn | 7.27 Bn | 29.60 Bn |
| 2 | Intuitive Surgical | 127.64 Bn | 122.42 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.92 Bn | 109.10 Bn | 6.34 Bn | 25.62 Bn |
| 4 | Stryker | 105.39 Bn | 101.91 Bn | 4.50 Bn | 14.19 Bn |
| 5 | Boston Scientific | 64.88 Bn | 64.34 Bn | 3.85 Bn | 10.92 Bn |
| 6 | Edwards Lifesciences | 49.92 Bn | 45.66 Bn | 1.35 Bn | 598.70 Mn |
| 7 | Alcon | 33.24 Bn | 31.79 Bn | 1.68 Bn | -1.00 Mn |
| 8 | Dexcom | 32.12 Bn | 30.18 Bn | 830.00 Mn | - |
| 9 | Steris | 20.83 Bn | 20.35 Bn | 684.20 Mn | 1.65 Bn |
| 10 | Enovis | 1.08 Bn | 1.06 Bn | 359.25 Mn | 1.28 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 3, 2026 | 1.28 Bn |
| Apr 3, 2026 | 1.33 Bn |
| Dec 31, 2025 | 1.30 Bn |
| Oct 3, 2025 | 1.36 Bn |
| Jul 4, 2025 | 1.39 Bn |
| Apr 4, 2025 | 1.39 Bn |
| Dec 31, 2024 | 1.33 Bn |
| Sep 27, 2024 | 1.35 Bn |
| Jun 28, 2024 | 1.34 Bn |
| Mar 29, 2024 | 1.34 Bn |
| Dec 31, 2023 | 466.16 Mn |
| Sep 29, 2023 | 395.00 Mn |
| Jun 30, 2023 | 400.00 Mn |
| Mar 31, 2023 | 285.00 Mn |
| Dec 31, 2022 | 259.28 Mn |
| Sep 30, 2022 | 449.22 Mn |
| Jul 1, 2022 | 449.46 Mn |
| Apr 1, 2022 | 2.07 Bn |
| Dec 31, 2021 | 2.09 Bn |
| Oct 1, 2021 | 1.63 Bn |